IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Q1 2021 Holdings

Filed 2021-05-17 | 28 holdings | $40.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arvinas Inc(ARVN)COM04335A105$11.8M178,50028.9%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$11.6M561,39828.3%
Arcus Biosciences Inc(RCUS)COM03969F109$11.2M400,00027.5%
Cardiff Oncology Inc(CRDF)COM14147L108$6.0M650,00014.7%
I MAB(NBP)SPONSORED ADS44975P103$25.7K530,0500.1%
Curis Inc(CRISEUR)COM NEW231269200$24.1K2,128,4000.1%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$23.5K548,3740.1%
4D Molecular Therapeutics in(FDMT)COM35104E100$16.4K378,2880.0%
Acceleron Pharma Inc(XLRN)COM00434H108$15.2K112,3630.0%
Gossamer BIO Inc(GOSS)COM38341P102$13.1K1,413,1380.0%
Ikena Oncology IncCOM45175G108$11.3K400,0000.0%
Avidity Biosciences Inc(RNA)COM05370A108$9.7K446,6410.0%
Dyne Therapeutics Inc(DYN)COM26818M108$9.1K583,6490.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$8.2K250,0000.0%
Chemocentryx Inc(CCXIEUR)COM16383L106$7.7K150,0760.0%
Design Therapeutics Inc(DSGN)COM25056L103$7.5K250,0000.0%
Connect Biopharma Hldgs LTDADS207523101$6.9K373,4920.0%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$6.5K320,4400.0%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$5.8K200,0000.0%
Revolution Medicines Inc(RVMD)COM76155X100$5.8K126,1360.0%
Kronos BIO Inc(KRON1USD)COM50107A104$4.3K146,1730.0%
Iveric BIO Inc(OPHTEUR)COM46583P102$4.2K680,0360.0%
Merus N VCOMN5749R100$4.2K200,0000.0%
Helix Acquisition CorpCOM CL AG4444C102$4.1K400,0000.0%
Edgewise Therapeutics Inc(EWTX)COM28036F105$4.1K125,0000.0%
Prometheus Biosciences IncCOM74349U108$3.7K200,0000.0%
Jiya Acquisition CorpCOM CL A47760M102$3.0K300,0000.0%
Foghorn Therapeutics Inc(FHTX)COM344174107$91169,1320.0%